HENDERSON, NV--(Marketwired - Oct 11, 2016) - United Health Products Inc. (OTCQB: UEEC) will hold a dial-in conference for shareholders, potential shareholders and those seeking to learn more about the company on October 13, 2016. Douglas Beplate, CEO, and Louis Schiliro, Director of Manufacturing, will discuss the company's current events and expansion of manufacturing capacities to meet the increase in current orders in the dental, veterinary, medical and retail markets. Management will also report on the future plans and efforts of the company to uplist to a higher exchange. The call-in conference will be Thursday, October 13th at 12:30 pm Eastern. To listen to the discussion:
1. Call your Dial-In Number: (712) 451-0011
2. Enter your Access Code: 291859.
Anyone who is interested and cannot access or attend the call can go to the company's website www.unitedhealthproductsinc.com and listen to the entire call which will be posted as an audio file on Friday, October 14th by noon EDT.
About United Health Products Inc.
United Health Products Inc. (UEEC) develops, manufactures, and markets patented hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp®, is derived from regenerated oxidized cellulose, which is all natural, and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on identifying new markets and applications for its product as well as ramping up sales in its current markets. For more on United Health Products Inc., visit: www.unitedhealthproductsinc.com
Safe Harbor Statement
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.